Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease

Ahmet Omma; Sevinc Can Sandikci; Seda Colak; Duygu Tecer; Cigdem Yucel; Zeynep Ozbalkan

doi:10.5114/pdia.2017.71269

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

6/2018
vol. 35

Send email

Copy url:

abstract:

Original paper

Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease

Ahmet Omma

,

Sevinc Can Sandikci

,

Seda Colak

,

Duygu Tecer

,

Cigdem Yucel

,

Zeynep Ozbalkan

Adv Dermatol Allergol 2018; XXXV (6): 609-613

DOI: https://doi.org/10.5114/pdia.2017.71269

Online publish date: 2017/11/08

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Omma A, Sandikci S, Colak S, Tecer D, Yucel C, Ozbalkan Z. Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2018;35(6):609-613. doi:10.5114/pdia.2017.71269.

APA

Omma, A., Sandikci, S., Colak, S., Tecer, D., Yucel, C.,  & Ozbalkan, Z. (2018). Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 35(6), 609-613. https://doi.org/10.5114/pdia.2017.71269

Chicago

Omma, Ahmet, Sevinc Can Sandikci, Seda Colak, Duygu Tecer, Cigdem Yucel,  and Zeynep Ozbalkan. 2018. "Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 35 (6): 609-613. doi:10.5114/pdia.2017.71269.

Harvard

Omma, A., Sandikci, S., Colak, S., Tecer, D., Yucel, C.,  and Ozbalkan, Z. (2018). Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 35(6), pp.609-613. https://doi.org/10.5114/pdia.2017.71269

MLA

Omma, Ahmet et al. "Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 35, no. 6, 2018, pp. 609-613. doi:10.5114/pdia.2017.71269.

Vancouver

Omma A, Sandikci S, Colak S, Tecer D, Yucel C, Ozbalkan Z. Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2018;35(6):609-613. doi:10.5114/pdia.2017.71269.

Introduction
Behçet’s disease (BD) is a complex multisystemic inflammatory disorder which is characterized by recurrent attacks of acute inflammation. As there is no universally recognized pathognomonic laboratory marker of BD, its diagnosis is still based on clinical findings.

Aim
To evaluate the role of calprotectin and ischemia modified albumin (IMA) as biomarkers in the assessment of disease activity of BD.

Material and methods
A total of 93 patients with BD and 62 age- and gender-matched healthy controls were included in the study. Disease activity was assessed with the BD Current Activity Form (BDCAF) score. Serum levels of calprotectin, high-sensitivity C-reactive protein (hsCRP) and IMA were measured in the patient and control groups.

Results
Serum levels of calprotectin, IMA and hsCRP in patients with BD were higher than those of the healthy control group (p < 0.001 for all). No correlations between calprotectin and IMA, hsCRP, erythrocyte sedimentation rate, CRP, or BDCAF score were found.

Conclusions
As the calprotectin level are increased in BD patients, it could be a candidate biomarker which plays a role in BD pathogenesis.

keywords:

Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease

Ahmet Omma , Sevinc Can Sandikci , Seda Colak , Duygu Tecer , Cigdem Yucel , Zeynep Ozbalkan

calprotectin, ischemia modified albumin, Behçet's disease, disease activity

Ahmet Omma

,

Sevinc Can Sandikci

,

Seda Colak

,

Duygu Tecer

,

Cigdem Yucel

,

Zeynep Ozbalkan